The emovis team focuses entirely on conducting clinical trials. It starts with the qualified and prompt feedback of our executive management’s feasibility and continues with the competent and quick response with regard to our investigators’ study protocols and the preparation of the source documents by our study coordinators. These are the first steps guaranteeing that your clinical study is conducted according to protocol at emovis.
emovis "lives" quality – in all areas. Therefore emovis is investing a great amount of time and effort in quality assurance of its tasks. Study site-specific SOPs, frequent advanced training and weekly team meetings are important tools to maintain quality and continuously question the processes. This is how emovis achieves high quality standards in conducting clinical trials and in cooperating with its sponsors, who, amongst other aspects, are characterized by the following criteria:
The source data is the heart of clinical trials. It initially only confirms the existence of the study participant. However, based on the source data we review the inclusion and exclusion criteria, make therapeutic decisions and extract study data. Therefore, emovis places special emphasis on detailed, verifiable, complete and high-quality source documents. All source data is available exclusively in paper form, because (currently) a German language documentation program meeting the FDA CRF Part 11 requirements is not available. Only the eCFR data carriers provided by the sponsors are enclosed in digital format; and those are reviewed on regular basis.
The contact process is as follows: